Gregory Bailey insider trades

Open-market stock purchases and sales by Gregory Bailey, Director at Serina Therapeutics, Inc, from SEC Form 4 filings since Jan 14, 2010.

Track record: 8% of 26 scored buys are up 5% or more since purchase, averaging -58%.

Recent trades

DateStockTradeValue
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)$4M
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)$15M
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)—
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)—
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)$1.7M
Apr 28, 2026BHVN Biohaven LtdBought (not open market)—
Mar 31, 2026SER Serina Therapeutics, IncBought (not open market)$116K
Nov 13, 2025BHVN Biohaven LtdBought$3M
Nov 7, 2025SER Serina Therapeutics, IncBought (not open market)—

Companies traded

  • SER Serina Therapeutics, Inc: 16 buys, last Jun 17, 2026
  • BHVN Biohaven Ltd: 10 buys, 42 sales, last Apr 28, 2026
  • AGE AgeX Therapeutics, Inc: other filings, last Jun 21, 2021
  • MDVN Medivation, Inc: 2 buys, 23 sales, last Oct 30, 2012

Get free alerts when Gregory Bailey files a new trade →